CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention

被引:3
|
作者
Wang, Yaolong [1 ,2 ,3 ]
Chen, Xi [1 ,2 ,3 ]
Yang, Yongxiu [1 ,2 ,3 ]
机构
[1] Lanzhou Univ, Dept Obstet & Gynecol, Hosp 1, Lanzhou 730000, Peoples R China
[2] Key Lab Gynecol Oncol Gansu Prov, Lanzhou, Gansu, Peoples R China
[3] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Gansu, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 03期
关键词
CircRNA; Ovarian cancer; Targeted therapy; Glucose metabolism; EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULAR RNAS; CELLS; PROMOTES; TUMOR; EXPRESSION; PROLIFERATION; SUPPRESSION; METASTASIS; ACTIVATION;
D O I
10.1007/s12094-023-03285-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer (OC) has the highest mortality rate among female reproductive system tumours, with limited efficacy of traditional treatments and 5-year survival rates that rarely exceed 40%. Circular RNA (circRNA) is a stable endogenous circular RNA that typically regulates protein expression by binding to downstream miRNA. It has been demonstrated that circRNAs play an important role in the proliferation, migration, and glucose metabolism (such as the Warburg effect) of OC and can regulate the expression of glucose metabolism-related proteins such as GLUT1 and HK2, promoting anaerobic glycolysis of cancer cells, increasing glucose uptake and ATP production, and affecting energy supply and biosynthetic substances to support tumour growth and invasion. This review summarises the formation and characteristics of circRNAs and focuses on their role in regulating glucose metabolism in OC cells and their potential therapeutic value, providing insights for identifying new therapeutic targets.
引用
收藏
页码:584 / 596
页数:13
相关论文
共 50 条
  • [21] Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
    Vaghari-Tabari, Mostafa
    Ferns, Gordon A.
    Qujeq, Durdi
    Andevari, Ali Nosrati
    Sabahi, Zahra
    Moein, Soheila
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) : 5512 - 5532
  • [22] Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
    Butler, Lisa M.
    Perone, Ylenia
    Dehairs, Jonas
    Lupien, Leslie E.
    de Laat, Vincent
    Talebi, Ali
    Loda, Massimo
    Kinlaw, William B.
    Swinnen, Johannes V.
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 159 : 245 - 293
  • [23] Therapeutic implications for ovarian cancer emerging from the Tumor Cancer Genome Atlas
    Verschraegen, Claire
    Lounsbury, Karen
    Howe, Alan
    Greenblatt, Marc
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 40 - 59
  • [24] CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer
    Liu, Yulin
    Jiang, Chenjun
    Liu, Qianqian
    Huang, Runchun
    Wang, Mancai
    Guo, Xiaohu
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (08): : 2321 - 2331
  • [25] CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer
    Yulin Liu
    Chenjun Jiang
    Qianqian Liu
    Runchun Huang
    Mancai Wang
    Xiaohu Guo
    Clinical and Translational Oncology, 2023, 25 : 2321 - 2331
  • [26] Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention
    Buonaiuto, Roberto
    Neola, Giuseppe
    Cecere, Sabrina Chiara
    Caltavituro, Aldo
    Cefaliello, Amedeo
    Pietroluongo, Erica
    De Placido, Pietro
    Giuliano, Mario
    Arpino, Grazia
    De Angelis, Carmine
    BIOMOLECULES, 2023, 13 (04)
  • [27] Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis
    Xiong, Siyi
    Tan, Xuanni
    Wu, Xiujuan
    Wan, Andi
    Zhang, Guozhi
    Wang, Cheng
    Liang, Yan
    Zhang, Yi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [28] The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
    Rongfu Tu
    Junpeng Ma
    Peng Zhang
    Ye Kang
    Xiaofan Xiong
    Junsheng Zhu
    Miao Li
    Chengsheng Zhang
    Cancer Cell International, 22
  • [29] Hydroxychloroquine: Key therapeutic advances and emerging nanotechnological landscape for cancer mitigation
    Low, Liang Ee
    Kong, Chee Kei
    Yap, Wei-Hsum
    Siva, Sangeetaprivya P.
    Gan, Siew Hua
    Siew, Wei Sheng
    Ming, Long Chiau
    Lai-Foenander, Ashley Sean
    Chang, Sui Kiat
    Lee, Wai-Leng
    Wu, Yongjiang
    Khaw, Kooi-Yeong
    Ong, Yong Sze
    Tey, Beng Ti
    Singh, Sachin Kumar
    Dua, Kamal
    Chellappan, Dinesh Kumar
    Goh, Bey-Hing
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 386
  • [30] The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
    Tu, Rongfu
    Ma, Junpeng
    Zhang, Peng
    Kang, Ye
    Xiong, Xiaofan
    Zhu, Junsheng
    Li, Miao
    Zhang, Chengsheng
    CANCER CELL INTERNATIONAL, 2022, 22 (01)